Inmaculada Soto

803 total citations
28 papers, 257 citations indexed

About

Inmaculada Soto is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Inmaculada Soto has authored 28 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Inmaculada Soto's work include Hemophilia Treatment and Research (10 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Inmaculada Soto is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Inmaculada Soto collaborates with scholars based in Spain, Chile and United Kingdom. Inmaculada Soto's co-authors include Ana Alonso, Victoria Álvarez, M. Martínez Moreno, Víctor Jiménez‐Yuste, Laura Gutiérrez, Carmen Sedano, Abelardo Bárez, Carlos López‐Larrea, Carlos Suárez Nieto and José María García‐Gala and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Obstetrics and Gynecology and BMC Health Services Research.

In The Last Decade

Inmaculada Soto

24 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inmaculada Soto Spain 9 187 56 46 34 33 28 257
P. Saidi United States 9 258 1.4× 73 1.3× 31 0.7× 20 0.6× 124 3.8× 9 353
M. Deforest Canada 6 338 1.8× 18 0.3× 74 1.6× 29 0.9× 67 2.0× 6 408
Eva‐Christine Weiss Austria 6 85 0.5× 212 3.8× 32 0.7× 44 1.3× 9 0.3× 14 319
Osamu Takamiya Japan 11 145 0.8× 113 2.0× 23 0.5× 12 0.4× 37 1.1× 45 339
Marion E. van Hoorn Netherlands 4 98 0.5× 156 2.8× 46 1.0× 24 0.7× 8 0.2× 6 241
Letícia Gonçalves Freitas Brazil 10 75 0.4× 265 4.7× 29 0.6× 19 0.6× 38 1.2× 14 371
I. Chilcott United Kingdom 5 110 0.6× 134 2.4× 44 1.0× 19 0.6× 7 0.2× 10 343
Frank Niemann Germany 5 78 0.4× 8 0.1× 60 1.3× 124 3.6× 19 0.6× 5 191
Juan Carlos Olivares‐Gazca Mexico 9 73 0.4× 12 0.2× 20 0.4× 14 0.4× 25 0.8× 47 241
Jordi Bellart Spain 11 139 0.7× 233 4.2× 32 0.7× 35 1.0× 16 0.5× 23 341

Countries citing papers authored by Inmaculada Soto

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Soto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Soto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Soto more than expected).

Fields of papers citing papers by Inmaculada Soto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Soto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Soto. The network helps show where Inmaculada Soto may publish in the future.

Co-authorship network of co-authors of Inmaculada Soto

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Soto. A scholar is included among the top collaborators of Inmaculada Soto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Soto. Inmaculada Soto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Soto, Inmaculada, et al.. (2024). Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective. SHILAP Revista de lepidopterología. 16(2). 204–219. 8 indexed citations
3.
Román, María, et al.. (2024). Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study. Haemophilia. 30(4). 950–958. 1 indexed citations
4.
Soto, Inmaculada, et al.. (2024). Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective. SHILAP Revista de lepidopterología. 16(3). 390–412. 2 indexed citations
5.
Gutiérrez, Laura, et al.. (2024). Rare bleeding disorders: Real-world data from a Spanish tertiary hospital. Blood Cells Molecules and Diseases. 106. 102837–102837. 3 indexed citations
6.
González‐López, Tomás José, Drew Provan, Abelardo Bárez, et al.. (2023). Primary and secondary immune thrombocytopenia (ITP): Time for a rethink. Blood Reviews. 61. 101112–101112. 18 indexed citations
7.
Vázquez‐Morón, Sonia, Álvaro Fernández‐Pardo, Júlia Oto, et al.. (2022). Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice. Journal of Clinical Medicine. 11(12). 3345–3345. 5 indexed citations
8.
Soto, Inmaculada, et al.. (2022). The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. BMC Health Services Research. 22(1). 115–115. 2 indexed citations
9.
Acebes‐Huerta, Andrea, et al.. (2021). Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns. Journal of Clinical Medicine. 10(5). 1073–1073. 9 indexed citations
10.
Soto, Inmaculada, et al.. (2015). Tuberculous Peritonitis in Patients on CAPD. Contributions to nephrology. 89. 79–86.
11.
Aznar, José A., Víctor Jiménez‐Yuste, R.M. Álvarez Pérez, et al.. (2012). Is on‐demand treatment effective in patients with severe haemophilia?. Haemophilia. 18(5). 738–742. 14 indexed citations
12.
Remor, Eduardo, Pilar Arranz, Manuel Quintana, et al.. (2005). Psychometric field study of the new haemophilia quality of life questionnaire for adults: The ‘Hemofilia‐QoL’. Haemophilia. 11(6). 603–610. 47 indexed citations
13.
Soto, Inmaculada, et al.. (2004). Successful induction of immune tolerance with FIX recombinant in a patient with haemophilia B with inhibitor. Haemophilia. 10(4). 401–404. 4 indexed citations
14.
Alonso, Ana, et al.. (2002). Acquired and inherited thrombophilia in women with unexplained fetal losses. American Journal of Obstetrics and Gynecology. 187(5). 1337–1342. 72 indexed citations
15.
Vargas, Mariángela, et al.. (1999). The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagulation & Fibrinolysis. 10(1). 39–39. 20 indexed citations
16.
García‐Gala, José María, et al.. (1997). Factor V Leiden (R506Q) and risk of venous thromboembolism: a case‐control study based on the Spanish population. Clinical Genetics. 52(4). 206–210. 27 indexed citations
17.
Soto, Inmaculada, et al.. (1992). 11‐Oxycorticosteroid‐Dependent Antibody in the Serum of a Patient with Bladder Neoplasm. Vox Sanguinis. 63(3). 227–231. 1 indexed citations
18.
Soto, Inmaculada, et al.. (1987). Lymph node response and its relationship to prognosis in carcinomas of the head and neck. Clinical Otolaryngology. 12(4). 241–247. 13 indexed citations
19.
Florenzano, R, et al.. (1981). [A study of patients who drop anti-hypertensive therapy (author's transl)].. PubMed. 109(11). 1060–4. 1 indexed citations
20.
Soto, Inmaculada, et al.. (1965). [Intermittent peritoneal dialysis. Preliminary experience].. PubMed. 93(6). 327–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026